Advanced search
Publication Cover
Modern Rheumatology Volume 27, 2017 - Issue 5
Journal homepage
578
Views
50
CrossRef citations to date
0
Altmetric
Original Article

A multicenter phase II prospective clinical trial of glucocorticoid for patients with untreated IgG4-related disease

Yasufumi MasakiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan, Correspondence[email protected]
,
Shoko MatsuiFirst Department of Internal Medicine, University of Toyama, Toyama, Japan,
,
Takako SaekiDepartment of Internal Medicine, Nagaoka Red Cross Hospital, Nagaoka, Japan,
,
Hiroto TsuboiDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,
,
Shintaro HirataThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Fukuoka, Japan,
,
Yasumori IzumiDepartment of Rheumatology, NHO Nagasaki Medical Center, Nagasaki, Japan,
,
Taiichiro MiyashitaDepartment of Rheumatology, NHO Nagasaki Medical Center, Nagasaki, Japan, ;Miyashita Rheumatology Clinic, Nagasaki, Japan,
,
Keita FujikawaDepartment of Rheumatology, Japan Community Healthcare Organization (JCHO), Isahaya General Hospital, Nagasaki, Japan,
,
Hiroaki DobashiDivision of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, Japan,
,
Kentaro SusakiDivision of Hematology, Rheumatology and Respiratory Medicine, Department of Internal Medicine, Faculty of Medicine, Kagawa University, Takamatsu, Japan,
,
Hisanori MorimotoDepartment of Internal Medicine, Mitoyo General Hospital, Kan'onji, Japan,
,
Kazutaka TakagiDivision of Hematology and Immunology, Maizuru-Kyousai Hospital, Kyoto, Japan,
,
Mitsuhiro KawanoDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan,
,
Tomoki OriguchiLaboratory of Basic Physical Therapy Science, Nagasaki Graduate School of Health Sciences, Nagasaki, Japan,
,
Yoko WadaDivision of Clinical Nephrology and Rheumatology, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan,
,
Naoki TakahashiDivision of Nephrology, Department of General Medicine, Faculty of Medical Sciences, University of Fukui, Fukui, Japan,
,
Masanobu HorikoshiDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,
,
Hiroshi OgishimaDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,
,
Yasunori SuzukiDivision of Rheumatology, Department of Internal Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan,
,
Takafumi KawanamiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,
,
Haruka Kawanami IwaoDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,
,
Tomoyuki SakaiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,
,
Yoshimasa FujitaDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,
,
Toshihiro FukushimaDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,
,
Masatoshi SaitoDivision of Respiratory Medicine, Kanazawa Medical University, Uchinada, Japan,
,
Ritsuro SuzukiDepartment of Oncology/Hematology, School of Medicine, Shimane University, Izumo, Japan,
,
Yuko MorikawaDepartment of Epidemiology and Public Health (School of Nursing), Kanazawa Medical University, Uchinada, Japan,
,
Tadashi YoshinoDepartment of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan,
,
Shigeo NakamuraDepartment of Pathology and Laboratory Medicine, Nagoya University Hospital, Nagoya, Japan,
,
Masaru KojimaDepartment of Anatomic and Diagnostic Pathology, Dokkyo University School of Medicine, Mibu, Japan, and
,
Nozomu KuroseDepartment of Pathology and Laboratory Medicine, Kanazawa Medical University, Uchinada, Japan
,
Yasuharu SatoDepartment of Pathology, Okayama University Graduate School of Medicine, Okayama, Japan,
,
Yoshiya TanakaThe First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health Japan, Fukuoka, Japan,
,
Susumu SugaiDivision of Hematology and Immunology, Kanazawa Medical University, Uchinada, Japan,
&
Takayuki SumidaDepartment of Internal Medicine, University of Tsukuba, Tsukuba, Japan,
show all
Pages 849-854 | Received 05 Jul 2016, Accepted 04 Nov 2016, Published online: 15 Dec 2016

References

  • Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med. 2001;344:732–8.
  • Masaki Y, Dong L, Kurose N, Kitagawa K, Morikawa Y, Yamamoto M, et al. Proposal for a new clinical entity, IgG4-positive multi-organ lymphoproliferative syndrome: analysis of 64 cases of IgG4-related disorders. Ann Rheum Dis. 2009;68:1310–15.
  • Kamisawa T, Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol. 2006;41:613–25.
  • Sato Y, Notohara K, Kojima M, Takata K, Masaki Y, Yoshino T. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int. 2010;60:247–58.
  • Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.
  • Masaki Y, Sugai S, Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol. 2010;37:1380–5.
  • Masaki Y, Iwao H, Nakajima A, Miki M, Sugai S, Umehara H. IgG4-related disease (IgG4 + MOLPS) – diagnostic criteria and diagnostic problems. Curr Immunol Rev. 2011;7:172–7.
  • Masaki Y, Kurose N, Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop. 2011;51:13–20.
  • Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Research program for intractable disease by Ministry of Health, Labor and Welfare (MHLW) Japan G4 team. A novel clinical entity, IgG4-related disease (IgG4RD): general concept and details. Mod Rheumatol. 2012;22:1–14.
  • Kamisawa T, Funata N, Hayashi Y, Eishi Y, Koike M, Tsuruta K, et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol. 2003;38:982–4.
  • Umehara H, Okazaki K, Masaki Y, Kawano M, Yamamoto M, Saeki T, et al. Comprehensive diagnostic criteria (CDC) for IgG4-related disease (IgG4RD), 2011. Mod Rheumatol. 2012;22:21–30.
  • Masaki Y, Shimizu H, Nakamura TS, Nakamura T, Nakajima A, Kawanami HI, et al. IgG4-related disease: diagnostic methods and therapeutic strategies in Japan. J Clin Exp Hematop. 2014;54(2):95–101.
  • Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25:579–86.
  • Trotti A, Colevas AD, Setser A, Rusch V, Jaques D, Budach V, et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol. 2003;13:176–81.
  • Uchida K, Yazaki A, Nishio A, Kusuda T, Koyabu M, Fukata M, et al. Long-term outcome of autoimmune pancreatitis. J Gastroenterol. 2009;44:726–32.
  • Hirano K, Isogawa A, Tada M, Isayama H, Takahara N, Miyabayashi K, et al. Long-term prognosis of autoimmune pancreatitis in terms of glucose tolerance. Pancreas. 2012;41:691–5.
  • Nanke Y, Kobashigawa T, Yago T, Kamatani N, Kotake S. A case of Mikulicz's disease, IgG4-related plasmacytic syndrome, successfully treated by corticosteroid and mizoribine, followed by mizoribine alone. Intern Med. 2010;49:1449–53.
  • Khan ML, Colby TV, Viggiano RW, Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymph Myeloma Leuk. 2010;10:217–19.
  • Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 level and prompt clinical improvement in IgG4-related systemic disease. Arthritis Rheum. 2010;62:1755–62.
  • Khosroshahi A, Stone JH. Treatment approaches to IgG4-related systemic disease. Curr Opin Rheumatol. 2011;23:67–71.
  • Topazian M, Witzig TE, Smyrk TC, Pulido JS, Levy MJ, Kamath PS, et al. Rituximab therapy for refractory biliary strictures in immunoglobulin G4-associated cholangitis. Clin Gastroenterol Hepatol. 2008;6:364–6.
  • Khosroshahi A, Carruthers MN, Deshpande V, Unizony S, Bloch DB, Stone JH. Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients. Medicine (Baltimore). 2012;91:57–66.
  • Carruthers MN, Topazian MD, Khosroshahi A, Witzig TE, Wallace ZS, Hart PA, et al. Rituximab for IgG4-related disease: a prospective, open-label trial. Ann Rheum Dis. 2015;74:1171–7.
  • Khosroshahi A, Wallace ZS, Crowe JL, Akamizu T, Azumi A, Carruthers MN, et al. International consensus guidance statement on the treatment of IgG4-related disease. Arthritis Rheumatol. 2015;67:1688–99.
  • Yamamoto M, Takahashi H, Takano K, Shimizu Y, Sakurai N, Suzuki C, et al. Efficacy of abatacept for IgG4-related disease over 8 months. Ann Rheum Dis. 2016;75:1576–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.